Amani Chowdhury

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

M. Piccart, M. Filetti, R. Salazar, 2022, The Lancet Oncology.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, R. Salazar, 2021, The Lancet Oncology.

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

R. Roylance, D. Ottaviani, Y. Wong, 2021, Cancers.

Treatment of metastatic hormone‐sensitive prostate cancer

J. Rane, R. Davda, W. Kinnaird, 2021, Trends in Urology & Men's Health.

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

M. Piccart, M. Filetti, F. Mazzoni, 2021, The Lancet. Oncology.

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

M. Filetti, R. Salazar, A. Maconi, 2022, European Journal of Cancer.

Exploratory study of using Magnetic resonance Prognostic Imaging markers for Radiotherapy In Cervix cancer (EMPIRIC): a prospective cohort study protocol

H. Tharmalingam, Amani Chowdhury, M. Abdul-Latif, 2024, BMJ Open.